1. Home
  2. NWGL vs ATHA Comparison

NWGL vs ATHA Comparison

Compare NWGL & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • ATHA
  • Stock Information
  • Founded
  • NWGL 2008
  • ATHA 2011
  • Country
  • NWGL Macau
  • ATHA United States
  • Employees
  • NWGL N/A
  • ATHA N/A
  • Industry
  • NWGL
  • ATHA Medicinal Chemicals and Botanical Products
  • Sector
  • NWGL
  • ATHA Health Care
  • Exchange
  • NWGL Nasdaq
  • ATHA Nasdaq
  • Market Cap
  • NWGL 21.2M
  • ATHA 10.6M
  • IPO Year
  • NWGL 2023
  • ATHA 2020
  • Fundamental
  • Price
  • NWGL $1.62
  • ATHA $0.31
  • Analyst Decision
  • NWGL
  • ATHA Buy
  • Analyst Count
  • NWGL 0
  • ATHA 4
  • Target Price
  • NWGL N/A
  • ATHA $11.25
  • AVG Volume (30 Days)
  • NWGL 146.5K
  • ATHA 573.2K
  • Earning Date
  • NWGL 06-10-2025
  • ATHA 05-09-2025
  • Dividend Yield
  • NWGL N/A
  • ATHA N/A
  • EPS Growth
  • NWGL N/A
  • ATHA N/A
  • EPS
  • NWGL N/A
  • ATHA N/A
  • Revenue
  • NWGL $21,539,347.00
  • ATHA N/A
  • Revenue This Year
  • NWGL N/A
  • ATHA N/A
  • Revenue Next Year
  • NWGL N/A
  • ATHA N/A
  • P/E Ratio
  • NWGL N/A
  • ATHA N/A
  • Revenue Growth
  • NWGL N/A
  • ATHA N/A
  • 52 Week Low
  • NWGL $1.04
  • ATHA $0.22
  • 52 Week High
  • NWGL $3.37
  • ATHA $3.67
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 58.98
  • ATHA 61.74
  • Support Level
  • NWGL $1.34
  • ATHA $0.26
  • Resistance Level
  • NWGL $1.75
  • ATHA $0.30
  • Average True Range (ATR)
  • NWGL 0.17
  • ATHA 0.02
  • MACD
  • NWGL 0.02
  • ATHA 0.00
  • Stochastic Oscillator
  • NWGL 75.00
  • ATHA 83.45

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Share on Social Networks: